Trinity Life Sciences Appoints Advisory Board

Trinity Life Sciences, a leader in global life sciences commercialization solutions, has announced its Board of Advisors, a group of independent, expert advisors that will help advance Trinity’s mission.

The Board of Advisors includes:

  • Susan Denman

    Ms. Denman is formerly with Johnson & Johnson where she held senior management roles including WW Vice President of Transfusion Medicine, WW VP of Innovation for Ortho Clinical Diagnostics, WW VP for the $2.4B Johnson’s Baby business, WW VP of J&J Health and Wellness Solutions and several roles within Janssen Ortho Biotech’s $4B Procrit franchise.

  • Scott Evangelista

    With over 30 years helping life sciences companies with their commercial challenges, Mr. Evangelista has held senior leadership roles with Deloitte, Swiftwater Group and Andersen Consulting and served as President Integrated Health Services at IQVIA and President and Chief Operating Officer at Ironshore Pharmaceuticals.

  • Kate Larkin

    Ms. Larkin has over 30 years of biopharmaceutical industry experience and U.S. Market Access experience, she has deep expertise in all aspects of Market Access strategy, Pricing & Contracting and Payer Relations. She held senior leadership positions at Bristol-Myers Squibb (BMS), Amgen and, most recently, SVP Value Access & Pricing at BMS.

  • Karenann (Kat) Terrell

    Ms. Terrell has been a driver of transformation for enterprises at scale through technology for her entire operating career across multiple industries. As a Chief Digital and Information officer in Pharma (GlaxoSmithKline and Baxter), Retail (Walmart), and Automotive (Mercedes/Chrysler), Ms. Terrell led technology organization transformation leading to digital business model opportunities.

  • John Corcoran

    Since founding Trinity in 1996, Mr. Corcoran has cultivated the heavily quantitative, cross-functional approach to consulting that has remained at the core of the company throughout its expansion of service offerings and its international growth of team members and offices. Trinity is the fourth company Mr. Corcoran has founded or co-founded, after successful endeavors in social media, medical devices, and pharma- and biotech-focused software development.

“My team and I are thrilled to be working with the foremost innovative thinkers in our industry,” said Leslie Orne, President & CEO of Trinity Life Sciences. “Their combined expertise is second to none and will serve as guiding voices as Trinity continues to transform the way life sciences companies think about and execute on their goals.”

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With over 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.